BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18685506)

  • 41. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
    van de Wijgert J; Verwijs MC
    BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [GynOphilus--a winning relay].
    Kovachev S
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():41-4. PubMed ID: 23236678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Lactobacillus rhamnosus and Lactobacillus acidophilus on bacterial vaginal pathogens.
    Bertuccini L; Russo R; Iosi F; Superti F
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):163-167. PubMed ID: 28580872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro evaluation on HeLa cells of protective mechanisms of probiotic lactobacilli against Candida clinical isolates.
    Coman MM; Verdenelli MC; Cecchini C; Silvi S; Orpianesi C; Caspani M; Mondello F; Cresci A
    J Appl Microbiol; 2015 Nov; 119(5):1383-90. PubMed ID: 26335148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
    Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
    Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial.
    Gille C; Böer B; Marschal M; Urschitz MS; Heinecke V; Hund V; Speidel S; Tarnow I; Mylonas I; Franz A; Engel C; Poets CF
    Am J Obstet Gynecol; 2016 Nov; 215(5):608.e1-608.e7. PubMed ID: 27342046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biofilms of vaginal Lactobacillus reuteri CRL 1324 and Lactobacillus rhamnosus CRL 1332: kinetics of formation and matrix characterization.
    Leccese Terraf MC; Juárez Tomás MS; Rault L; Le Loir Y; Even S; Nader-Macías ME
    Arch Microbiol; 2016 Sep; 198(7):689-700. PubMed ID: 27146055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata.
    Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
    Anaerobe; 2015 Aug; 34():132-8. PubMed ID: 26028405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
    Köhler GA; Assefa S; Reid G
    Infect Dis Obstet Gynecol; 2012; 2012():636474. PubMed ID: 22811591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaginal microbiome.
    Buchta V
    Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spectrum of Lactobacillus species present in healthy vagina of Indian women.
    Garg KB; Ganguli I; Das R; Talwar GP
    Indian J Med Res; 2009 Jun; 129(6):652-7. PubMed ID: 19692744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus La-14 Attenuate Gardnerella vaginalis-Infected Bacterial Vaginosis in Mice.
    Jang SE; Jeong JJ; Choi SY; Kim H; Han MJ; Kim DH
    Nutrients; 2017 May; 9(6):. PubMed ID: 28545241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial.
    Ou YC; Fu HC; Tseng CW; Wu CH; Tsai CC; Lin H
    BMC Womens Health; 2019 Jul; 19(1):103. PubMed ID: 31340789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli.
    Reid G; Burton J; Hammond JA; Bruce AW
    J Med Food; 2004; 7(2):223-8. PubMed ID: 15298771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of lactobacilli and probiotics in maintaining vaginal health.
    Borges S; Silva J; Teixeira P
    Arch Gynecol Obstet; 2014 Mar; 289(3):479-89. PubMed ID: 24170161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study.
    Reznichenko H; Henyk N; Maliuk V; Khyzhnyak T; Tynna Y; Filipiuk I; Veresniuk N; Zubrytska L; Quintens J; Richir K; Gerasymov S
    J Low Genit Tract Dis; 2020 Jul; 24(3):284-289. PubMed ID: 32091443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations.
    Juárez Tomás MS; De Gregorio PR; Leccese Terraf MC; Nader-Macías ME
    Eur J Pharm Sci; 2015 Nov; 79():87-95. PubMed ID: 26299342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract.
    Nader-Macías MEF; De Gregorio PR; Silva JA
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00787. PubMed ID: 34609059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months.
    Rossi A; Rossi T; Bertini M; Caccia G
    Arch Gynecol Obstet; 2010 Jun; 281(6):1065-9. PubMed ID: 20012637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.